1. Dynamic evaluation of the immune infiltrate and immune function genes as predictive markers for neoadjuvant chemotherapy in hormone receptor positive, HER2 negative breast cancer. (2nd September 2018) Authors: Matikas, Alexios; Lövrot, John; Ramberg, Anna; Eriksson, Margareta; Lindsten, Therese; Lekberg, Tobias; Hedenfalk, Ingrid; Loman, Niklas; Bergh, Jonas; Hatschek, Thomas; Erlandsson, Ann; Foukakis, Theodoros Journal: Oncoimmunology Issue: Volume 7:Number 9(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. RE: Receptor Conversion in Distant Breast Cancer Metastases: A Systematic Review and Meta-analysis. (29th March 2018) Authors: Matikas, Alexios; Foukakis, Theodoros; Bergh, Jonas Journal: Journal of the National Cancer Institute Issue: Volume 110:Number 11(2018) Page Start: 1280 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Axillary Evaluation in the Setting of a Preoperative Ductal Cancer in Situ (DCIS) Diagnosis. Do Guidelines (Mis)Guide?. Issue 2 (February 2020) Authors: Karakatsanis, Andreas; Valachis, Antonios; Pistioli, Lida; Charalampoudis, Petros; DiMicco, Rosa; Foukakis, Theodoros; Wärnberg, Fredrik Journal: European journal of surgical oncology Issue: Volume 46:Issue 2(2020) Page Start: e63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Neutropenic complications in the PANTHER phase III study of adjuvant tailored dose-dense chemotherapy in early breast cancer. (2nd January 2020) Authors: Papakonstantinou, Antroula; Hedayati, Elham; Hellström, Mats; Johansson, Hemming; Gnant, Michael; Steger, Günther; Greil, Richard; Untch, Michael; Moebus, Volker; Loibl, Sibylle; Foukakis, Theodoros; Bergh, Jonas; Matikas, Alexios Journal: Acta oncologica Issue: Volume 59:Number 1(2020) Page Start: 75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy and safety of tailored and dose‐dense adjuvant chemotherapy and trastuzumab for resected HER2‐positive breast cancer: Results from the phase 3 PANTHER trial. Issue 6 (18th December 2019) Authors: Papakonstantinou, Antroula; Matikas, Alexios; Bengtsson, Nils Olof; Malmström, Per; Hedayati, Elham; Steger, Guenther; Untch, Michael; Hübbert, Laila; Johansson, Hemming; Hellström, Mats; Gnant, Michael; Loibl, Sibylle; Greil, Richard; Moebus, Volker; Foukakis, Theodoros; Bergh, Jonas Journal: Cancer Issue: Volume 126:Issue 6(2020) Page Start: 1175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Discordance of PD-L1 status between primary and metastatic breast cancer: A systematic review and meta-analysis. (September 2021) Authors: Boman, Caroline; Zerdes, Ioannis; Mårtensson, Kira; Bergh, Jonas; Foukakis, Theodoros; Valachis, Antonios; Matikas, Alexios Journal: Cancer treatment reviews Issue: Volume 99(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial. Issue 1 (January 2018) Authors: Colleoni, Marco; Luo, Weixiu; Karlsson, Per; Chirgwin, Jacquie; Aebi, Stefan; Jerusalem, Guy; Neven, Patrick; Hitre, Erika; Graas, Marie-Pascale; Simoncini, Edda; Kamby, Claus; Thompson, Alastair; Loibl, Sibylle; Gavilá, Joaquín; Kuroi, Katsumasa; Marth, Christian; Müller, Bettina; O'Reilly, Seam... Journal: Lancet oncology Issue: Volume 19:Issue 1(2018) Page Start: 127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Effects of Exercise on Chemotherapy Completion and Hospitalization Rates: The OptiTrain Breast Cancer Trial. (7th August 2019) Authors: Mijwel, Sara; Bolam, Kate A.; Gerrevall, Jacob; Foukakis, Theodoros; Wengström, Yvonne; Rundqvist, Helene Journal: Oncologist Issue: Volume 25:Number 1(2020) Page Start: 23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Integrated multi‐omics profiling of high‐grade estrogen receptor‐positive, HER2‐negative breast cancer. Issue 12 (29th July 2021) Authors: Wang, Kang; Li, Lun; Franch‐Expósito, Sebastià; Le, Xin; Tang, Jun; Li, Qing; Wu, Qianxue; Bassaganyas, Laia; Camps, Jordi; Zhang, Xiang; Li, Hongyuan; Foukakis, Theodoros; Xiang, Tingxiu; Wu, Jiong; Ren, Guosheng Journal: Molecular oncology Issue: Volume 16:Issue 12(2022) Page Start: 2413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Implementing neoadjuvant endocrine strategies in ER-positive, HER2-negative breast cancer. Issue 4 (3rd April 2017) Authors: Matikas, Alexios; Foukakis, Theodoros; Michalakis, Ilias; Georgoulias, Vassilis Journal: Expert review of anticancer therapy Issue: Volume 17:Issue 4(2017) Page Start: 319 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗